Cargando…
A new polysaccharide platform constructs self-adjuvant nanovaccines to enhance immune responses
BACKGROUND: Nanovaccines have shown the promising potential in controlling and eradicating the threat of infectious diseases worldwide. There has been a great need in developing a versatile strategy to conveniently construct diverse types of nanovaccines and induce potent immune responses. To that e...
Autores principales: | Chen, Sisi, Yang, Liu, Ou, Xia, Li, Jin-Yu, Zi, Cheng-Ting, Wang, Hao, Hu, Jiang-Miao, Liu, Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281129/ https://www.ncbi.nlm.nih.gov/pubmed/35836236 http://dx.doi.org/10.1186/s12951-022-01533-3 |
Ejemplares similares
-
Self-adjuvanting cancer nanovaccines
por: Liao, Zhiyun, et al.
Publicado: (2022) -
An antigen self-assembled and dendritic cell-targeted nanovaccine for enhanced immunity against cancer
por: Zhang, Yunting, et al.
Publicado: (2023) -
A "trained immunity" inducer-adjuvanted nanovaccine reverses the growth of established tumors in mice
por: Li, Duo, et al.
Publicado: (2023) -
Potential of Polyethyleneimine as an Adjuvant To Prepare Long-Term and Potent Antifungal Nanovaccine
por: Jin, Zhao, et al.
Publicado: (2022) -
Self-Assembled, Adjuvant/Antigen-Based Nanovaccine Mediates Anti-Tumor Immune Response against Melanoma Tumor
por: Rajendrakumar, Santhosh Kalash, et al.
Publicado: (2018)